Quantum-Si Inc QSI
π Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-09-04 |
| Shares Out. | 217,760,000 |
| Website | quantum-si.com/ β |
| Phone | 12034587100 |
| Employees | 145 |
| Revenue | $344,000 |
| Gross Profit | $172,000 |
| Net Income | -$23.5M |
| Free Cash Flow | -$93.7M |
| Total Assets | $193.6M |
| Total Liabilities | $13.4M |
| Equity | $180.2M |
About Quantum-Si Inc
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
Quantum-Si Inc is a publicly traded company under the ticker symbol QSI on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
7 analysts (2026-09-01)

